Articles published by Merck & Co., Inc.![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL®9 Published in Pediatrics
September 05, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]()
Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]() ![]() ![]() ![]() ![]() ![]() ![]()
U.S. FDA Approves Merck’s ERVEBO® (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older
August 03, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]()
Merck Announces Second-Quarter 2023 Financial Results
August 01, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]() ![]() ![]() ![]()
Merck Announces Fourth-Quarter 2023 Dividend
July 25, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|